SCHEMBL4740207

SCHEMBL4740207

CCS(=O)(=O)Nc1cc(CO)cc(N(C)CC2CC2C)n1

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 18/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2026059 0.79 BACE1 (0.50) BACE1
SCHEMBL12578838 0.65 BACE1 (0.56) BACE1
SCHEMBL12578623 0.65 BACE1 (0.50) BACE1
SCHEMBL831403 0.64 BACE1 (0.63) BACE1
SCHEMBL831402 0.64 BACE1 (0.63) BACE1
SCHEMBL2028914 0.64 BACE1 (0.56) BACE1
SCHEMBL2255225 0.64 BACE1 (0.56) BACE1
SCHEMBL831254 0.63 BACE1 (0.50) BACE1
SCHEMBL4078824 0.63 BACE1 (0.50) BACE1
SCHEMBL2018884 0.62 BACE1 (0.46) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740581-A4 2, 4, 6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO INC (US) 2008-01-23 EP disclosed
EP-1740581-A1 2, 4, 6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER\"S DISEASE Merck and Co., Inc. (US) 2007-01-10 EP disclosed
WO-2005103043-A1 2, 4, 6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE MERCK & CO., INC. (US) 2005-11-03 WO disclosed